Indivior Share Price (INDV)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Indivior	LSE:INDV	London	Ordinary Share	GB00BRS65X63	ORD USD0.10

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+5.50p	+2.67%	211.50p	18,760,555	11:32:36

Bid Price		Offer Price	High Price	Low Price	Open Price
202.60p		203.40p	210.00p	201.10p	205.60p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	809.24	101.43	5.92	33.9	1,540.4

Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Indivior (INDV) Latest News (1)

Indivior News

Date	Time	Source	Headline
16/11/2018	15:52	UKREG	Indivior PLC Director Declaration
13/11/2018	16:22	UKREG	Indivior PLC Holding(s) in Company
09/11/2018	15:00	UKREG	Indivior PLC Block listing Interim Review
06/11/2018	14:37	UKREG	Indivior PLC Holding(s) in Company
06/11/2018	13:00	PRNUS	Indivior Announces Upcoming Investor Events
06/11/2018	07:00	UKREG	Indivior PLC Indivior Announces Upcoming Investor Events
02/11/2018	12:38	ALNCF	Alliance News Flash Headline
01/11/2018	11:53	ALNC	TOP NEWS: Indivior Revenue Down As Competitor Cuts Market Share
01/11/2018	11:26	PRNUS	Indivior Announces Nine Month and Third Quarter 2018 Results
01/11/2018	11:01	UKREG	Indivior PLC 3rd Quarter Results

More Indivior News

Indivior Takeover Rumours

Indivior (INDV) Share Charts

1 Year Indivior Chart

1 Month Indivior Chart

Intraday Indivior Chart

Indivior (INDV) Discussions and Chat

Indivior Forums and Chat

Date	Time	Title	Posts
04/11/2018	12:45	INDIVIOR THE PILL WITH NO CHEERS OR BEERS	117
03/10/2018	14:06	RB. de-merger	488
31/7/2018	12:45	Indivior (INDV) IP Battle Status	-
28/7/2018	13:16	Indivior (INDV) One to Watch on Monday	2
14/5/2018	12:52	Indivior (INDV) Settles Legal Patent Battle	-

Add a New Thread

Indivior (INDV) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
2018-11-17 11:32:41	211.50	241,924	511,669.26	AT
2018-11-17 11:32:41	211.50	642,117	1,358,077.46	AT
2018-11-17 11:32:36	211.50	18,590	39,317.85	AT
2018-11-17 11:32:36	211.50	660,707	1,397,395.31	AT
2018-11-17 11:32:36	211.50	204,744	433,033.56	AT

View all Indivior trades in real-time

Indivior (INDV) Top Chat Posts

Date	Subject
17/11/2018 08:20	Indivior Daily Update: Indivior is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker INDV. The last closing price for Indivior was 206p. Indivior has a 4 week average price of 175.55p and a 12 week average price of 169.30p. The 1 year high share price is 504.60p while the 1 year low share price is currently 169.30p. There are currently 728,306,837 shares in issue and the average daily traded volume is 2,542,674 shares. The market capitalisation of Indivior is £1,540,368,960.26. Read Full Thread Reply
01/10/2018 22:32	pwhite73: The writing is on the wall for this company. The share price was trading at 490p in June 2018. There are a number of problems here. 1. The opioid addiction market is too competitive and relatively easy to enter. 2. The injunction against Dr Reddy is only temporary. 3. Donald Trump and the State Department are soon to announce their own nationwide programme to combat opioid addiction in the US. The shares can be traded as it bounces off the bottom but because of the share price you need lots of upfront capital to make any decent money. Those who think the share price is about to mount a recovery are mistaken. When the next set of adverse news is released it will plunge again. Read Full Thread Follow Reply
21/8/2018 08:44	naed: Very quite here......share price constantly loosing value? Read Full Thread Follow Reply
12/7/2018 15:03	steeplejack: Good recovery today,hope this presages a favourable court review. Plus... Indivior got a boost as Bank of America Merrill Lynch upgraded the stock to 'buy' following recent share price weakness. Read Full Thread Follow Reply
11/7/2018 09:15	mj19: http://www.cityam.com/289071/indivior-share-price-dives-wake-us-market-competition Read Full Thread Follow Reply
16/6/2018 11:58	kazoom: I am new to Indivior so apologies if this doesn't make sense - please feel free to correct me ;-) When I read "So Dr Reddy is really interested in testing punitive damages! I do wonder." I wonder if Dr Reddy are actually engaged in some Trump style bargaining. I note here Https://www.investegate.co.uk/indivior-plc--indv-/rns/indivior-settlement-with-par-pharmaceutical/201805140700088858N/ (14-may) that INDV settled with PAR phara and that Par get the ability to sell the generic from Jan 2023 Maybe Reddy are angling for a similar settlement? Also if Par don't have the rights until 2023 - why would we expect the courts to grant a later comer like Reddy earlier access to the market? On that basis (and of course it could be nonsense) it seems to be that the outcome is likely to be much better than Friday's share price movement would suggest. Any thoughts? Read Full Thread Follow Reply
02/5/2018 13:40	sarkasm: http://uk.advfn.com/stock-market/london/indivior-INDV/share-news/Indivior-PLC-1st-Quarter-Results/77315882 Read Full Thread Follow Reply
01/11/2017 11:47	gregmorg: Yup, as you say, who knows with this one! Good thing is it is increasingly looking a less dangerous/more secure company. So after the 2nd November we then roll on to that other tester of our investors steel --on the 14th. Will see how that coding scenario has developed . It could be the stock starts to put the days of serious uncertainty behind it. Revenues are looking good and growing very respectably. But what about the veins!~! Thinking of patience(or apathy!) I have been a little puzzled by GSK's share price performance in recent time but am hoping this baptism of fire gears up/fires up the new CEO. OR what! As for my other pharma, IMB, I do wish, Steeplejack, I had more noted your disposal some months back and so questioned my own rationale. Good call. Now I am left waiting for Vaping to kick in! Hopefully this is made less painless by a continued good stream of dividends. Let's see what tomorrow brings on IND . Unfortunately I cannot listen in to the live investors meeting as I have some silly cross country trail commitment. Hopefully I can listen in later in the day. Read Full Thread Follow Reply
31/10/2017 21:06	gregmorg: Steeplejack. I understand the Committee vote at the end was 18 for and one against.The latter was on the basis of this was nothing new! This, I hasten to add, is purely my understanding. I did say this Committee is advisory but it does look as if the recommendation to the FDA is going our way. A few concerns were raised re the results of the 300mg doses( as opposed to the 100mg) and a few small issues that resulted, but this does not appear to have affected the outcome. So possibly it is looking OK!. We both have experiences of erratic share price performance across the financial reporting period so its important to maintain the longer view. Read Full Thread Follow Reply
07/6/2016 08:40	gregmorg: Makes sense. Mind you, in terms of share price movement.The usual consensus is that a third give back after a significant share price rise is healthy! Steeplejack you mentio Merrills change of investment stance but purely for my edification can you say what their public stance was beforehand please? i was very happy to see that last piece of patent news so feel the longer term investment view remains intact.Essentially am sitting tight and awaiting events. Read Full Thread Follow Reply
05/12/2015 11:12	gregmorg: The share sales position has been very confusing with the legacy JAB disposal technically taking place between 9th Nov and 30 Nov. so no announcement in that period! My understanding is the institution which took the stake covered it with a series of complex hedging arrangements presumably allowing them to place their stock/or much of it, in the market with the minimum of fuss/publicity. The JAB disposal took time to soak up possibly weakening the share price over a period .Even 9th November could be a false start date as positions would have been taken well before then. So we could have some explanation for the share price performance since the summer! Actually I am less concerned with the recent term share price performance but more concerned with the longer term development of the product and revenue base. The Co's research and teach in date of 9 Dec is hopefully a significant event rather than one buying time. Not long to wait. Read Full Thread Follow Reply

Indivior share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:31 V: D:20181118 06:48:16